Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pathogen cell membrane and cell wall components are essential structural assemblies that define the boundary and maintain the internal environment of bacteria, fungi, and parasites (StatPearls, 2023). These components, such as the peptidoglycan matrix in bacteria and the glucan-chitin complex in fungi, provide the mechanical strength necessary to withstand high internal osmotic pressure (NIH, 2022). Additionally, the plasma membranes of these organisms often contain unique lipids or sterols, such as ergosterol in fungi, which are distinct from human cholesterol (NCBI, 2021). Because these structures are fundamental to microbial survival and often unique to the pathogen, they serve as the primary targets for the majority of clinically used antimicrobial drugs (Nature Reviews Microbiology, 2017). Antibiotics like penicillins and glycopeptides interfere with the assembly of the cell wall, leading to cell rupture, while agents like polymyxins and polyenes target the membrane to cause lethal leakage of cellular contents (PubMed, 2020). However, the therapeutic use of these drugs is often complicated by the emergence of resistance mechanisms, such as target site modification or the production of degradative enzymes like beta-lactamases (Journal of Fungi, 2017).
Antimicrobial agents targeting these components work by either inhibiting the biosynthesis of essential structural polymers like peptidoglycan or beta-glucans, or by directly disrupting the physical integrity of the lipid bilayer (StatPearls, 2023). Inhibition of synthesis often leads to osmotic lysis, while membrane disruption causes the leakage of essential ions and metabolites, resulting in rapid cell death (Nature Reviews Microbiology, 2017).
10 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogen cell membrane and cell wall components.